The current financial score of AtriCure Inc is 8.94. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 153.60M, representing a year-over-year increase of 12.83%, while its net profit experienced a year-over-year increase of 244.67%.
The current valuation score of AtriCure Inc is 5.65. Its current P/E ratio is -618.22, which is -96.18% below the recent high of -23.63 and -0.49% above the recent low of -621.27.
The current earnings forecast score of AtriCure Inc is 8.00. The average price target is 55.50, with a high of 65.00 and a low of 43.00.
The current price momentum score of AtriCure Inc is 4.84. Currently, the stock price is trading between the resistance level at 63.60 and the support level at 50.33, making it suitable for range-bound swing trading.
The current institutional shareholding score of AtriCure Inc is 10.00. The latest institutional shareholding proportion is 95.14%, representing a quarter-over-quarter decrease of 18.53%. The largest institutional shareholder is First Eagle Investment, holding a total of 297.64K shares, representing 0.01% of shares outstanding, with 71.20% increase in holdings.
The current risk assessment score of AtriCure Inc is 7.00. The company's beta value is 1.27. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.